Patent · US Active

PPAR gamma agonists for treatment of multiple sclerosis

US9539249B2 · kind B2 · utility

4Cited by
2References
6Claims
0Family size

Assignee

Inventor

Key dates

Filing dateMay 8, 2015
Grant dateJan 10, 2017
Priority date—
Expiry dateMay 8, 2035

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P25/28
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Methods of treatment of multiple sclerosis (MS) with PPARγ agonists, and in particular with the compound of formula (I) known as INT131:

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.